"Designing Growth Strategies is in our DNA"

Nuclear Medicine Market Size, Share & COVID-19 Impact Analysis, By Type (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End-user (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI101812

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Installed Base of PET/PET-CT Scanners – For Key Countries, 2015 and 2019
    2. Installed Base of Gamma Cameras – For Key Countries, 2019
    3. PET/PET-CT Procedure Volume –for Key Countries, 2019
    4. Reimbursement Scenario- For Key Countries
    5. New Product Launches
    6. Key Industry Developments
    7. Pipeline Analysis
    8. Impact of COVID-19 on the Market
  5. Global Nuclear Medicine Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostics
        1. PET Radiopharmaceuticals
          1. FDG-PET/18F
          2. 68Ga
          3. 68Cu
          4. 11C
          5. Others
        2. SPECT Radiopharmaceuticals
          1. Technetium-99m
          2. Iodine-123
          3. Xenon-133
          4. Thallium-201
          5. Others
      2. Therapeutics
    3. Market Analysis, Insights and Forecast – By Application
      1. Neurology
      2. Cardiology
      3. Oncology
      4. Others
    4. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Nuclear Medicine Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostics
        1. PET Radiopharmaceuticals
          1. FDG-PET/18F
          2. 68Ga
          3. 68Cu
          4. 11C
          5. Others
        2. SPECT Radiopharmaceuticals
          1. Technetium-99m
          2. Iodine-123
          3. Xenon-133
          4. Thallium-201
          5. Others
      2. Therapeutics
    3. Market Analysis, Insights and Forecast – By Application
      1. Neurology
      2. Cardiology
      3. Oncology
      4. Others
    4. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Nuclear Medicine Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostics
        1. PET Radiopharmaceuticals
          1. FDG-PET/18F
          2. 68Ga
          3. 68Cu
          4. 11C
          5. Others
        2. SPECT Radiopharmaceuticals
          1. Technetium-99m
          2. Iodine-123
          3. Xenon-133
          4. Thallium-201
          5. Others
      2. Therapeutics
    3. Market Analysis, Insights and Forecast – By Application
      1. Neurology
      2. Cardiology
      3. Oncology
      4. Others
    4. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Nuclear Medicine Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostics
        1. PET Radiopharmaceuticals
          1. FDG-PET/18F
          2. 68Ga
          3. 68Cu
          4. 11C
          5. Others
        2. SPECT Radiopharmaceuticals
          1. Technetium-99m
          2. Iodine-123
          3. Xenon-133
          4. Thallium-201
          5. Others
      2. Therapeutics
    3. Market Analysis, Insights and Forecast – By Application
      1. Neurology
      2. Cardiology
      3. Oncology
      4. Others
    4. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Nuclear Medicine Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Diagnostics
        1. PET Radiopharmaceuticals
          1. FDG-PET/18F
          2. 68Ga
          3. 68Cu
          4. 11C
          5. Others
        2. SPECT Radiopharmaceuticals
          1. Technetium-99m
          2. Iodine-123
          3. Xenon-133
          4. Thallium-201
          5. Others
      2. Therapeutics
    3. Market Analysis, Insights and Forecast – By Application
      1. Neurology
      2. Cardiology
      3. Oncology
      4. Others
    4. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Diagnostic Centers
      3. Others
  10. Competitive Analysis
    1. Global Market Share Analysis (2020)
    2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Lantheus Medical Imaging, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Cardinal Health
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Norgine B.V.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Advanced Accelerator Applications
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Nordion (Nordion (Canada) Inc.)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Bayer AG
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Curium
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Bracco Diagnostic Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Jubilant Life Sciences Limited
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. GE Healthcare (General Electric Company)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 01: Global Nuclear Medicine Market Revenue Breakdown (USD billion, %) by Region, 2020 & 2028

Figure 02: Global Nuclear Medicine Market Value Share (%), by Type, 2020 & 2028

Figure 03: Global Nuclear Medicine Market Forecast (USD billion), by Diagnostic Radiopharmaceuticals, 2017-2028

Figure 04: Global Nuclear Medicine Market Forecast (USD billion), Therapeutic Radiopharmaceuticals, 2017-2028

Figure 05: Global Nuclear Medicine Market Value Share (%), by Application, 2020 & 2028

Figure 06: Global Nuclear Medicine Market Forecast (USD billion), by Neurology, 2017-2028

Figure 07: Global Nuclear Medicine Market Forecast (USD billion), by Cardiology, 2017-2028

Figure 08: Global Nuclear Medicine Market Forecast (USD billion), by Oncology, 2017-2028

Figure 09: Global Nuclear Medicine Market Forecast (USD billion), by Others, 2017-2028

Figure 10: Global Nuclear Medicine Market Value Share (%), by End User, 2020 & 2028

Figure 11: Global Nuclear Medicine Market Forecast (USD billion), Hospitals & Clinics, 2017-2028

Figure 12: Global Nuclear Medicine Market Forecast (USD billion), by Diagnostic centers, 2017-2028

Figure 13: Global Nuclear Medicine Market Forecast (USD billion), by Others, 2017-2028

Figure 14: Global Nuclear Medicine Market Value (USD billion), by Region, 2020 & 2028

Figure 15: North America Nuclear Medicine Market Value (USD billion), by Type, 2020 & 2028

Figure 16: North America Nuclear Medicine Market Value Share (%), by Type, 2020

Figure 17: North America Nuclear Medicine Market Value (USD billion), by Application, 2020 & 2028

Figure 18: North America Nuclear Medicine Market Value Share (%), by Application, 2020

Figure 19: North America Nuclear Medicine Market Value (USD billion), by End User, 2020 & 2028

Figure 20: North America Nuclear Medicine Market Value Share (%), by End User, 2020

Figure 21: North America Nuclear Medicine Market Value (USD billion), by Country, 2020 & 2028

Figure 22: North America Nuclear Medicine Market Value Share (%), by Country, 2020

Figure 23: Europe Nuclear Medicine Market Value (USD billion), by Type, 2020 & 2028

Figure 24: Europe Nuclear Medicine Market Value Share (%), by Type, 2020

Figure 25: Europe Nuclear Medicine Market Value (USD billion), by Application, 2020 & 2028

Figure 26: Europe Nuclear Medicine Market Value Share (%), by Application, 2020

Figure 27: Europe Nuclear Medicine Market Value (USD billion), by End User, 2020 & 2028

Figure 28: Europe Nuclear Medicine Market Value Share (%), by End User, 2020

Figure 29: Europe Nuclear Medicine Market Value (USD billion), by Country, 2020 & 2028

Figure 30: Europe Nuclear Medicine Market Value Share (%), by Country, 2020

Figure 31: Asia Pacific Nuclear Medicine Market Value (USD billion), by Type, 2020 & 2028

Figure 32: Asia Pacific Nuclear Medicine Market Value Share (%), by Type, 2020

Figure 33: Asia Pacific Nuclear Medicine Market Value (USD billion), by Application, 2020 & 2028

Figure 34: Asia Pacific Nuclear Medicine Market Value Share (%), by Application, 2020

Figure 35: Asia Pacific Nuclear Medicine Market Value (USD billion), by End User, 2020 & 2028

Figure 36: Asia Pacific Nuclear Medicine Market Value Share (%), by End User, 2020

Figure 37: Asia Pacific Nuclear Medicine Market Value (USD billion), by Country/ Sub-region, 2020 & 2028

Figure 38: Asia Pacific Nuclear Medicine Market Value Share (%), by Country/ Sub-region, 2020

Figure 39: Rest of the World Nuclear Medicine Market Value (USD billion), by Type, 2020 & 2028

Figure 40: Rest of the World Nuclear Medicine Market Value Share (%), by Type, 2020

Figure 41: Rest of the World Nuclear Medicine Market Value (USD billion), by Application, 2020 & 2028

Figure 42: Rest of the World Nuclear Medicine Market Value Share (%), by Application, 2020

Figure 43: Rest of the World Nuclear Medicine Market Value (USD billion), by End User, 2020 & 2028

Figure 44: Rest of the World Nuclear Medicine Market Value Share (%), by End User, 2020

Table 01: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by Type, 2017–2028

Table 02: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by PET Radiopharmaceuticals, 2017–2028

Table 03: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by SPECT Radiopharmaceuticals, 2017–2028

Table 04: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by Application, 2017–2028

Table 05: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by End User, 2017–2028

Table 06: Global Nuclear Medicine Market Revenue (USD billion) Forecast, by Region, 2017–2028

Table 07: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 08: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by PET Radiopharmaceuticals, 2017-2028

Table 09: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by SPECT Radiopharmaceuticals, 2017–2028

Table 10: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by Application, 2017-2028

Table 11: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by End User, 2017-2028

Table 12: North America Nuclear Medicine Market Revenue (USD billion) Forecast, by Country, 2017-2028

Table 13: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 14: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by PET Radiopharmaceuticals, 2017-2028

Table 15: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by SPECT Radiopharmaceuticals, 2017-2028

Table 16: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by Application, 2017-2028

Table 17: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by End User, 2017-2028

Table 18: Europe Nuclear Medicine Market Revenue (USD billion) Forecast, by Country, 2017-2028

Table 19: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 20: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by PET Radiopharmaceuticals, 2017-2028

Table 21: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by SPECT Radiopharmaceuticals, 2017-2028

Table 22: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by Application, 2017-2028

Table 23: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by End User, 2017-2028

Table 24: Asia Pacific Nuclear Medicine Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2017-2028

Table 25: Rest of the World Nuclear Medicine Market Revenue (USD billion) Forecast, by Type, 2017-2028

Table 26: Rest of the World Nuclear Medicine Market Revenue (USD billion) Forecast, by PET Radiopharmaceuticals, 2017-2028

Table 27: Rest of the World Nuclear Medicine Market Revenue (USD billion) Forecast, by SPECT Radiopharmaceuticals, 2017-2028

Table 28: Rest of the World Nuclear Medicine Market Revenue (USD billion) Forecast, by Application, 2017-2028

Table 29: Rest of the World Nuclear Medicine Market Revenue (USD billion) Forecast, by End User, 2017-2028

  • Mar, 2022
  • 2020
  • 2017-2019
  • 169

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X